Sweetch Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 16

Sweetch General Information

Description

Developer of a hyper-personalized engagement platform intended to improve clinical outcomes for people with chronic conditions. The company's platform allows individuals to achieve their health goals with hyper-personalized recommendations in the right time, tone, and real-world context every step of the way throughout their health journey, enabling pharmaceutical companies, device manufacturers, payers, and healthcare providers to build continuous relationships and engage with every individual patient with chronic conditions, at scale.

Contact Information

Website
www.sweetch.com
Formerly Known As
iPrevent
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Jabotinsky Street 5
  • Ramat Gan 5252006
  • Israel
Primary Industry
Enterprise Systems (Healthcare)
Corporate Office
  • Jabotinsky Street 5
  • Ramat Gan 5252006
  • Israel

Sweetch Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sweetch Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 01-Aug-2024 Completed Generating Revenue
6. Later Stage VC (Series A) 19-Jul-2021 Completed Generating Revenue
5. Later Stage VC 28-May-2020 Completed Generating Revenue
4. Later Stage VC 25-Feb-2019 Completed Generating Revenue
3. Early Stage VC (Series A) 07-Apr-2016 Completed Generating Revenue
2. Early Stage VC $325K $1.64M Completed Startup
1. Seed Round 01-Apr-2015 $1.31M $1.31M Completed Startup
To view Sweetch’s complete valuation and funding history, request access »

Sweetch Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A3
Preferred A2
Preferred A1 67,211 $0.010000 $19.49 $19.49 1x $19.49 20.05%
To view Sweetch’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Sweetch Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a hyper-personalized engagement platform intended to improve clinical outcomes for people with chronic cond
Enterprise Systems (Healthcare)
Ramat Gan, Israel
49 As of 2022

Palo Alto, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sweetch Competitors (28)

One of Sweetch’s 28 competitors is Glooko, a Venture Capital-Backed company based in Palo Alto, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Glooko Venture Capital-Backed Palo Alto, CA
Lumeon Formerly VC-backed Boston, MA
Relatient Private Equity-Backed Franklin, TN
DatStat Corporate Backed or Acquired Seattle, WA
AirStrip Venture Capital-Backed San Antonio, TX
You’re viewing 5 of 28 competitors. Get the full list »

Sweetch Patents

Sweetch Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4380699-A1 Systems and methods for prediction, prevention and management of chronic and autoimmune diseases Pending 05-Aug-2021
US-20240296958-A1 Systems and methods for prediction, prevention and management of chronic and autoimmune diseases Pending 05-Aug-2021

Sweetch Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sweetch Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Tenmile Venture Capital Minority
Entrée Capital Venture Capital Minority
FinTLV Ventures Venture Capital Minority
InsurTech.vc Venture Capital Minority
Kortex Ventures Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

Sweetch FAQs

  • When was Sweetch founded?

    Sweetch was founded in 2013.

  • Where is Sweetch headquartered?

    Sweetch is headquartered in Ramat Gan, Israel.

  • What is the size of Sweetch?

    Sweetch has 49 total employees.

  • What industry is Sweetch in?

    Sweetch’s primary industry is Enterprise Systems (Healthcare).

  • Is Sweetch a private or public company?

    Sweetch is a Private company.

  • What is Sweetch’s current revenue?

    The current revenue for Sweetch is .

  • How much funding has Sweetch raised over time?

    Sweetch has raised $37.2M.

  • Who are Sweetch’s investors?

    Tenmile, Entrée Capital, FinTLV Ventures, InsurTech.vc, and Kortex Ventures are 5 of 16 investors who have invested in Sweetch.

  • Who are Sweetch’s competitors?

    Glooko, Lumeon, Relatient, DatStat, and AirStrip are some of the 28 competitors of Sweetch.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »